During the past decade, Winelands Medical Research Centre conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 12 clinical trials were completed, i.e. on average, 92.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 10 clinical trials were completed. i.e. 333.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Winelands Medical Research Centre" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Coherus Biosciences, Inc." with 2 trials sponsored, "EMD Serono" with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Winelands Medical Research Centre" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Shire" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Winelands Medical Research Centre" are "Rheumatoid Arthritis" (6 trials), "Systemic Lupus Erythematosus" (4 trials), "Lupus Erythematosus, Systemic" (3 trials), "Arthritis, Rheumatoid" (1 trials) and "Plaque Psoriasis" (1 trials). Many other conditions were trialed in "Winelands Medical Research Centre" in a lesser frequency.

Most popular intervention types in "Winelands Medical Research Centre" are "Drug" (16 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Baricitinib" (4 trials), "Etanercept" (3 trials), "Atacicept 150 mg" (2 trials) and "CHS-0214" (2 trials). Other intervention names were less common.

The vast majority of trials in "Winelands Medical Research Centre" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Winelands Medical Research Centre". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Winelands Medical Research Centre, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Winelands Medical Research Centre, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".